Apotheken
|
Doctor
|
Drugs
|
Hospital
|
Interactions
|
MiGeL
|
Registration owner
|
Services
Recent Registrations
Price comparison
Price comparison and Component
Brand name
Component
Registration owner
Indication
Interaction
Unwanted Effect
Swissmedic-# (5-digit)
Pharmacode
Product
Package Size
EFP
CP
SB
DC
Composition
Registr. Holder
Category
January
-
February
-
March
- April -
May
-
June
-
July
-
August
-
September
-
Oktober
-
November
-
December
|
2002
-
2003
-
2004
-
2005
-
2006
-
2007
-
2008
-
2009
-
2010
-
2011
- 2012 -
2013
-
2014
-
2015
-
2016
-
2017
-
2018
-
2019
-
2020
-
2021
-
2022
-
2023
-
2024
-
2025
April 2012 - 22 products
IP
CI
Voltaren forte
30 g
PR
PR
k.A.
Gel: Diclofenacum Diethylaminum 23.2 mg
Haleon Schweiz AG
D
FB
G
IP
Zoledronat-Teva onco 4 mg/ 5 ml
108.31
134.10
10 %
Concentrate for infusion: Acidum Zoledronicum 4mg / 5ml
Teva Pharma AG
B / SL / SG
FB
G
IP
CI
Mometasonfuroat Sandoz
140 unidose(s)
7.73
17.65
10 %
Sandoz
Pharmaceuticals AG
B / SL / SG
FB
G
IP
CI
Mometasonfuroat Sandoz
3 x 140 unidose(s)
19.70
37.85
10 %
Sandoz
Pharmaceuticals AG
B / SL / SG
FB
G
IP
CI
Tamsulosin T Sandoz
10 Tablet(s)
4.72
14.35
10 %
Delayed release tablets: Tamsulosini Hydrochloridum
Sandoz
Pharmaceuticals AG
B / SL / SG
FB
G
IP
CI
Tamsulosin T Sandoz
30 Tablet(s)
11.33
28.70
10 %
Delayed release tablets: Tamsulosini Hydrochloridum
Sandoz
Pharmaceuticals AG
B / SL / SG
FB
G
IP
CI
Tamsulosin T Sandoz
100 Tablet(s)
33.06
52.35
10 %
Delayed release tablets: Tamsulosini Hydrochloridum
Sandoz
Pharmaceuticals AG
● 
B / SL / SG
FB
G
L
IP
CI
PP
Inlyta 1 mg
28 Tablet(s)
341.34
387.65
10 %
Coated tablets: Axitinibum 1 mg
Pfizer AG
A / SL
FB
G
L
IP
CI
PP
Inlyta 1 mg
56 Tablet(s)
682.69
758.90
10 %
Coated tablets: Axitinibum 1 mg
Pfizer AG
A / SL
FB
G
L
IP
CI
PP
Inlyta 3 mg
28 Tablet(s)
1024.04
1130.10
10 %
Coated tablets: Axitinibum 3 mg
Pfizer AG
A / SL
FB
G
L
IP
CI
PP
Inlyta 5 mg
28 Tablet(s)
1706.74
1872.60
10 %
Coated tablets: Axitinibum 5 mg
Pfizer AG
A / SL
FB
G
L
IP
CI
PP
Inlyta 5 mg
56 Tablet(s)
3413.48
3728.80
10 %
Coated tablets: Axitinibum 5 mg
Pfizer AG
A / SL
FB
G
L
IP
CI
PP
Inlyta 7 mg
28 Tablet(s)
2389.44
2615.10
10 %
Coated tablets: Axitinibum 7 mg
Pfizer AG
A / SL
FB
G
IP
Sayana,
Injektionssuspension (104
mg/0.65 ml)
syringe(s)
PR
PR
k.A.
Medroxyprogesteroni Acetas 104 mg
Pfizer AG
B / LPPV
FB
G
IP
CI
Voltaren Dolo forte
50 g
PR
PR
k.A.
Gel: Diclofenacum Diethylaminum 23.2 mg
Haleon Schweiz AG
D
FB
G
IP
CI
Voltaren Dolo forte
100 g
PR
PR
k.A.
Gel: Diclofenacum Diethylaminum 23.2 mg
Haleon Schweiz AG
D
FB
G
IP
CI
Voltaren Dolo forte
120 g
PR
PR
k.A.
Gel: Diclofenacum Diethylaminum 23.2 mg
Haleon Schweiz AG
D
FB
G
IP
CI
Voltaren Dolo forte
150 g
PR
PR
k.A.
Gel: Diclofenacum Diethylaminum 23.2 mg
Haleon Schweiz AG
D
FB
G
IP
CI
Voltaren Dolo forte
180 g
PR
PR
k.A.
Gel: Diclofenacum Diethylaminum 23.2 mg
Haleon Schweiz AG
D
FB
G
IP
CI
Voltaren forte
50 g
6.41
12.05
k.A.
Gel: Diclofenacum Diethylaminum 23.2 mg
Haleon Schweiz AG
D
FB
G
IP
CI
Voltaren forte
100 g
11.28
20.80
k.A.
Gel: Diclofenacum Diethylaminum 23.2 mg
Haleon Schweiz AG
D
FB
G
IP
CI
CM
Coop Vitality Ibuprofen 400
10 Tablet(s)
PR
PR
k.A.
Coated tablets: Ibuprofenum 400 mg
Coop Vitality Health
Care GmbH
D
FB
G
show caption
Red = Original
CM
= Co-Marketing
EFP = Ex-Factory-Price, exkl. VAT CHF
Green = Generic Drug
V/S
= vaccine/blood product
CP = Consumer Price, inkl. VAT CHF
Black = not classified
A
= Anesthetic
PR = Price request
Gray background = Pending Permission Extension
SIP
= Short Information for Professionals
SB = Selbstbehalt
H
= Homeopathics
IP
= Information for Professionals
DC = Daily Cost
A
= Anthroposophics
CI
= Consumer Information
SL = Official reimbursement list of Switzerland.
Ph
= Phytotherapeutics
L
= Limitations
SO = Original according to SL
Cas Reg.Nr. = CAS Registry
G
= Google Search by Product Name
SG = Generic according to SL
P
= Import parallel
FB
= Drugs Feedback
LPPA = Liste des produits pharmaceutiques pour application spéciale
Legal Disclaimer
ATC-Browser
|
Drugs A-Z
|
Recent Registrations
2025
©ywesee GmbH
Settings
|
Help
|
FAQ
|
Login
|
Contact
|
Home